Vicarious Surgical Inc (RBOT)
0.43
+0.10
(+30.26%)
USD |
NYSE |
May 17, 16:00
0.428
0.00 (0.00%)
After-Hours: 20:00
Vicarious Surgical Cash from Financing (Quarterly): 0.002M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.002M |
| December 31, 2023 | 0.034M |
| September 30, 2023 | 44.23M |
| June 30, 2023 | 0.162M |
| March 31, 2023 | 0.273M |
| December 31, 2022 | 8.812M |
| September 30, 2022 | 0.10M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.059M |
| March 31, 2022 | 0.174M |
| December 31, 2021 | -0.486M |
| September 30, 2021 | 191.06M |
| June 30, 2021 | 0.039M |
| March 31, 2021 | 1.548M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.486M
Minimum
Dec 2021
191.06M
Maximum
Sep 2021
18.92M
Average
0.162M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Ekso Bionics Holdings Inc | 3.657M |
| Perspective Therapeutics Inc | 0.352M |
| Xtant Medical Holdings Inc | 0.325M |
| Asensus Surgical Inc | 0.811M |
| Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.46M |
| Cash from Investing (Quarterly) | -0.144M |
| Free Cash Flow | -59.57M |
| Free Cash Flow Per Share (Quarterly) | -0.0823 |
| Free Cash Flow Yield | -87.50% |